Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on March 13, 2008
Chest, doi:10.1378/chest.07-1959
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
chest.07-1959v1
133/5/1088    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Stolz, D.
Right arrow Articles by Mueller, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stolz, D.
Right arrow Articles by Mueller, C.

Use of B-type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Daiana Stolz, MD; Tobias Breidthardt, MD; Mirjam Christ-Crain, MD; Roland Bingisser, MD; David Miedinger, MD; Jörg Leuppi, MD; Beat Mueller, MD; Michael Tamm, MD and Christian Mueller, MD.

Department of Internal Medicine, University Hospital Basel, Switzerland, Clinic for Pneumology and Respiratory Cell Research, University Hospital Basel, Switzerland

chmueller{at}uhbs.ch

Abstract

Background: In patients with chronic obstructive pulmonary disease (COPD) prognosis might be determined at least in part by the extent of cardiac stress induced by hypoxia and pulmonary arterial hypertension.

Methods: B-type natriuretic peptide (BNP), a quantitative marker of cardiac stress, was determined in 208 consecutive patients presenting to the emergency department with an acute exacerbation of COPD (AECOPD). The accuracy of BNP to predict death at 2-years follow up was evaluated as the primary endpoint. The need for intensive care and in-hospital mortality were determined as secondary endpoints.

Results: BNP levels were significantly elevated during the acute exacerbation compared to recovery (65pg/ml [34-189] vs. 45pg/ml [25-85], p<0.001), particularly in those patients requiring ICU treatment (105pg/ml [66-553] vs. 60pg/ml [31-169], p=0.007]. In multivariate Cox regression analysis BNP accurately predicted the need for ICU care (HR 1.13; 95%CI 1.03-1.24 for an increase in BNP of 100pg/ml; p=0.008). In a receiver operating characteristic (ROC) analysis to evaluate the potential of BNP levels to predict short- and long-term mortality the area under the curves was 0.55 (SD 0.71, 95%CI 0.41-0.68) and 0.56 (SD 0.53; 95%CI 0.45-0.66) respectively.

Conclusions: In patients with AECOPD, BNP levels independently predict the need for intensive care. However, BNP levels failed to adequately predict short-and long-term mortality in AECOPD patients.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American College of Chest Physicians.